SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-11-271857
Filing Date
2011-10-14
Accepted
2011-10-14 17:12:15
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d239148ds3.htm S-3 275126
2 FORM OF INDENTURE, BETWEEN REGISTRANT AND ONE OR MORE TRUSTEES TO BE NAMED d239148dex47.htm EX-4.7 340253
3 OPINION OF LATHAM & WATKINS LLP d239148dex51.htm EX-5.1 24407
4 STATEMENT OF COMPUTATION OF RATIOS d239148dex121.htm EX-12.1 31236
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d239148dex231.htm EX-23.1 1669
6 GRAPHIC g239148111.jpg GRAPHIC 3454
7 GRAPHIC g239148222.jpg GRAPHIC 2348
  Complete submission text file 0001193125-11-271857.txt   681977
Mailing Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037
Business Address 11085 NORTH TORREY PINES ROAD SUITE 300 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-177338 | Film No.: 111142394
SIC: 2834 Pharmaceutical Preparations